scholarly article | Q13442814 |
P2093 | author name string | L Sher | |
M McGrath | |||
L Podesta | |||
A Hoffman | |||
F Villamil | |||
J Rozga | |||
A D Moscioni | |||
E Morsiani | |||
E LePage | |||
G Woolf | |||
P2860 | cites work | Therapeutic plasmapheresis for liver failure after hepatectomy | Q69403830 |
Performance of a new hybrid artificial liver support system using hepatocytes entrapped within a hydrogel | Q69403833 | ||
Hybrid bioartificial liver in hepatic failure: preliminary clinical report | Q69707073 | ||
Sorption-filtration therapy for chronic liver disease: in vitro testing and clinical correlation | Q70572811 | ||
Effects of serial resin hemoperfusion in fulminant hepatic failure | Q71185633 | ||
Extracorporeal pig-liver perfusoon in treatment of hepatic coma due to fulminant hepatitis | Q93699085 | ||
Controlled trial of exchange-transfusion therapy in fulminant hepatitis | Q93731472 | ||
Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane | Q34474877 | ||
Plasma and Brain Amino Acids in Fulminant Hepatic Failure and their Relationship to Hepatic Encephalopathy | Q39117120 | ||
Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis | Q39442228 | ||
Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy | Q39568662 | ||
Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells | Q41090200 | ||
Acute and subacute fulminant hepatic failure: the role of liver transplantation | Q43740566 | ||
Development of a hybrid bioartificial liver | Q44265532 | ||
Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure | Q46350658 | ||
Improved liver function following treatment with an extracorporeal liver assist device | Q47353027 | ||
Earlier charcoal haemoperfusion in fulminant hepatic failure | Q48895106 | ||
Hepatic support with hepatocyte suspensions in a permeable membrane dialyzer | Q50952965 | ||
Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. | Q51772704 | ||
Use of a novel bioartificial liver in a patient with acute liver insufficiency. | Q52037739 | ||
Acute hepatic failure treated by cross circulation. | Q52727765 | ||
False neurotransmitters and hepatic failure. | Q53915012 | ||
Total blood washout and exchange. A valuable tool in acute hepatic coma and Reye's syndrome | Q67560010 | ||
Bioartificial liver using hepatocytes on biosilon microcarriers: treatment of chemically induced acute hepatic failure in rats | Q67938433 | ||
A new hybrid artificial liver using a combination of hepatocytes and biomatrix | Q68202073 | ||
Development of bioartificial liver: bilirubin conjugation in Gunn rats | Q68782748 | ||
New method of hepatocyte transplantation and extracorporeal liver support | Q68899761 | ||
Treatment of acute hepatic coma by ex vivo baboon and human liver perfusions | Q69373022 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 538-44; discussion 544-6 | |
P577 | publication date | 1994-05-01 | |
P1433 | published in | Annals of Surgery | Q4767866 |
P1476 | title | A bioartificial liver to treat severe acute liver failure | |
P478 | volume | 219 |
Q30845184 | A biodialysis system for liver support tested in a porcine hepatic failure model |
Q40818552 | A tightly regulated immortalized human fetal hepatocyte cell line to develop a bioartificial liver |
Q34575268 | ARDS and the multiple organ dysfunction syndrome. Common mechanisms of a common systemic process |
Q77777651 | An update on high-yield hepatocyte isolation methods and on the potential clinical use of isolated liver cells |
Q44101006 | Analysis of Multivariables during Porcine Liver Digestion to Improve Hepatocyte Yield and Viability for Use in Bioartificial Liver Support Systems |
Q55476379 | Artificial Liver and Renal Support System for Cynomolgus Monkeys with Surgery-Induced Acute Renal Failure: A Preclinical Study. |
Q28237883 | Artificial and bioartificial liver support |
Q74616161 | Artificial liver |
Q33949286 | Artificial liver support devices for fulminant liver failure |
Q92323574 | Bioartificial liver support systems for acute liver failure: A systematic review and meta-analysis of the clinical and preclinical literature |
Q73314605 | Biodialysis: a new liver support system |
Q33692604 | Bioreactors for hybrid liver support: historical aspects and novel designs |
Q35781240 | Cellular therapies for liver replacement |
Q41622955 | Cerebral edema and intracranial pressure monitoring |
Q24540124 | Clinical application of bioartificial liver support systems |
Q44413698 | Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial |
Q33866914 | Comparison between bioartificial and artificial liver for the treatment of acute liver failure in pigs |
Q73305017 | Effect of bioartificial liver in pigs with total ischemic liver failure |
Q44216238 | Effect of ethanolamine on liver regeneration after 90% hepatectomy in rats |
Q40360684 | Effectiveness of polyamidoamine dendrimers modified with tripeptide growth factor, glycyl-L-histidyl-L-lysine, for enhancement of function of hepatoma cells |
Q36415556 | Effects of a bioartificial liver support system on acetaminophen induced acute liver failure canines. |
Q48411037 | Effects of large-pore hemofiltration in a swine model of fulminant hepatic failure |
Q33328652 | Efficacy and limitation of apheresis therapy in critical care |
Q40894231 | Establishment of a highly differentiated immortalized human hepatocyte cell line as a source of hepatic function in the bioartificial liver |
Q40985888 | Evaluation of extracorporeal bioartificial liver devices |
Q41513472 | Experimental research on TECA-I bioartificial liver support system to treat canines with acute liver failure |
Q73438218 | Experimental xenotransplantation of fresh isolated and cryopreserved pig hepatocytes: a biochemical and morphological study |
Q74452131 | Extracorporeal liver perfusion |
Q40875080 | Extracorporeal liver support: cell-based therapy for the failing liver |
Q33731099 | Extracorporeal support and hepatocyte transplantation in acute liver failure and cirrhosis |
Q33540212 | Fulminant hepatic failure |
Q40507204 | Functional activity of human hepatoma cells transfected with adenovirus-mediated hepatocyte nuclear factor (HNF)-4 gene |
Q38554811 | Hepatocyte cell therapy in liver disease. |
Q35578597 | Hepatocyte hollow-fibre bioreactors: design, set-up, validation and applications |
Q81646877 | Hollow fiber bioartificial liver utilizing collagen-entrapped porcine hepatocyte spheroids |
Q42059920 | How valid is emergency liver transplantation for acute liver necrosis in patients with multiple-organ failure? |
Q40899786 | Immobilization of ligand-modified polyamidoamine dendrimer for cultivation of hepatoma cells |
Q38901747 | Immortalization of Human Fetal Hepatocyte by Ectopic Expression of Human Telomerase Reverse Transcriptase, Human Papilloma Virus (E7) and Simian Virus 40 Large T (SV40 T) Antigen Towards Bioartificial Liver Support |
Q35018059 | Improving the next generation of bioartificial liver devices |
Q71867547 | Influence of Warm Ischemia on Isolation and Primary Culture of Hepatocytes from Rat Liver for a Hybrid Artificial Liver |
Q46500091 | Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: an experimental study |
Q73305039 | Intrasplenic transplantation of immortalized human fetal hepatocytes prolongs the survival of 90% hepatectomized rats |
Q45862646 | Liver stem cells: prospects for treatment of inherited and acquired liver diseases |
Q40966829 | Liver transplantation and its long-term management in children |
Q41622936 | Liver transplantation for fulminant hepatic failure: North American experience |
Q74617427 | Long-term treatment of patients with acute exacerbation of chronic liver failure by albumin dialysis |
Q34015343 | Natural antibodies and the host immune responses to xenografts |
Q40609212 | New directions in acute liver failure |
Q44789617 | Pharmacokinetic considerations in development of a bioartificial liver |
Q46141325 | Plasma separation for artificial liver support |
Q74267311 | Polyurethane membrane as an efficient immobilization carrier for high-density culture of rat hepatocytes in the fixed-bed reactor |
Q74480512 | Rapid resolution of brain edema and improved cerebral perfusion pressure following the molecular adsorbent recycling system in acute liver failure patients |
Q36680260 | Renal dysfunction associated with liver transplantation |
Q33762458 | Review article: liver support systems in acute hepatic failure |
Q40851415 | Review article: the management of acute liver failure |
Q74428921 | Role of plasmapheresis in the management of acute hepatic failure in children |
Q73793494 | Semiautomatic macroencapsulation of large numbers of porcine hepatocytes by coextrusion with a solution of AN69 polymer |
Q41073936 | Stimulation of liver functions in hierarchical co-culture of bone marrow cells and hepatocytes |
Q40683796 | Survival and differentiation of porcine hepatocytes encapsulated by semiautomatic device and allotransplanted in large number without immunosuppression |
Q36304257 | Technology insight: liver support systems |
Q41622946 | Timing and candidacy for transplantation in acute liver failure: the European experience |
Q73850402 | Transplantation of cells in matrices for tissue regeneration |
Q40986109 | Treatment of hepatic failure--1996: current concepts and progress toward liver dialysis. |
Q77087308 | What progress with artificial livers? |
Q41696788 | What should we expect from a bioartificial liver in fulminant hepatic failure? |
Q77070950 | Xenotransplantation |
Q73925431 | [Acute liver failure] |
Q77346610 | [Intraperitoneal transplantation of isolated hepatocytes of the pig: the implantable bioartificial liver] |
Q75198763 | [Liver replacement therapy. Reliable indications in acute liver failure] |
Search more.